Of the 13 lncRNAs evaluated, five ( NEAT1 , SNHG16 , MEG3 , MALAT1 and H19 ) were found to be differentially expressed in brain samples from sALS patients as compared to healthy controls, and two others ( MIAT and SNHG1 ) showed trends towards differential expression but did not reach statistical significance ( Fig. 5 ).
← all excerpts
LncRNA levels in the central nervous system as novel potential players and biomarkers in amyotrophic lateral sclerosis.
1
—
—